A scientist from the Cancer Biology Research Center at Sanford Research in Sioux Falls, S.D., is scheduled to present the upcoming civil engineering seminar at NDSU. Dr. Subhash C. Chauhan, will present “Significance of MUC13 in Pancreatic Cancer” on Wednesday, Sept. 26, at 1 p.m. in Research 1, room 148/154. Refreshments will be served.
Chauhan also is an associate professor in the OB/GYN Department and Basic Biomedical Science Division of the Sanford School of Medicine at the University of South Dakota.
According to the abstract for Chauhan’s talk, pancreatic cancer is one of the most lethal malignancies, and the high death rate of is attributed to a lack of reliable methods of early diagnosis.
Chauhan’s research is investigating MUC13, a newly identified transmembrane mucin, which is present in ovarian, gastric and colon cancer. The research focuses on the expression and functions of MUC13 in pancreatic cancer to determine the potential for early diagnosis and the mucin’s role in pancreatic cancer pathogenesis.
Chauhan earned his doctorate in 1997 from the Central Drug Research Institute in India. Prior to joining Sanford Research in 2005, Chauhan was a research associate in the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center. He has been an electron microscopy scientific officer at the Sanjay Gandhi Post Graduate Institute of Medical Sciences in India.
Chauhan’s primary research interest is developing molecular markers for early cancer diagnosis and targeted therapy for cancer treatment. He has given more than 20 invited lectures nationally and internationally. His research is supported by grants from the National Institutes of Health, the state of South Dakota and Merck Corp.
NDSU is recognized as one of the nation's top 108 public and private universities by the Carnegie Commission on Higher Education.